ESC Premium Access

Elevated interleukin-6 and interleukin-18 concentrations predict residual inflammatory risk both before and after interleukin-1beta inhibition with canakinumab

Congress Presentation

About the speaker

Doctor Paul M Ridker

Brigham and Women's Hospital, Boston (United States of America)
34 presentations

4 more presentations in this session

PD1-blocking immune checkpoint inhibitor therapy for malignant melanoma induces left ventricular dysfunction

Speaker: Doctor L. Michel (Essen, DE)


Th17 signature, autoimmunity and differentially expressed genes in cardiomyopathy and heart failure

Speaker: Professor M. Cunningham (Oklahoma City, US)


Reparative macrophage transplantation for myocardial repair: a refinement of bone marrow mononuclear cell-based therapy

Speaker: Mr M. Podaru (London, GB)


Effects of a selective small-molecule formyl peptide receptor 2 agonist on post myocardial inflammation and left ventricular structure-function relationships

Speaker: Doctor R. Garcia (Princeton, US)


Access the full session

Immuno-inflammation as therapeutic target in heart failure

Speakers: Doctor P. Ridker, Doctor L. Michel, Professor M. Cunningham, Mr M. Podaru, Doctor R. Garcia

About the event


ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb